96 related articles for article (PubMed ID: 2228341)
1. Lack of interaction between famotidine and warfarin.
De Lepeleire I; Van Hecken A; Verbesselt R; Tjandra-Maga TB; Buntinx A; Distlerath L; De Schepper PJ
Int J Clin Pharmacol Res; 1990; 10(3):167-71. PubMed ID: 2228341
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib does not significantly alter the pharmacokinetics or hypoprothrombinemic effect of warfarin in healthy subjects.
Karim A; Tolbert D; Piergies A; Hubbard RC; Harper K; Wallemark CB; Slater M; Geis GS
J Clin Pharmacol; 2000 Jun; 40(6):655-63. PubMed ID: 10868317
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a potential tigecycline-warfarin drug interaction.
Zimmerman JJ; Raible DG; Harper DM; Matschke K; Speth JL
Pharmacotherapy; 2008 Jul; 28(7):895-905. PubMed ID: 18576904
[TBL] [Abstract][Full Text] [Related]
4. The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.
Schwartz JI; Bugianesi KJ; Ebel DL; De Smet M; Haesen R; Larson PJ; Ko A; Verbesselt R; Hunt TL; Lins R; Lens S; Porras AG; Dieck J; Keymeulen B; Gertz BJ
Clin Pharmacol Ther; 2000 Dec; 68(6):626-36. PubMed ID: 11180023
[TBL] [Abstract][Full Text] [Related]
5. Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
Van Hecken A; Depré M; Verbesselt R; Wynants K; De Lepeleire I; Arnout J; Wong PH; Freeman A; Holland S; Gertz B; De Schepper PJ
J Clin Pharmacol; 1999 May; 39(5):495-500. PubMed ID: 10234597
[TBL] [Abstract][Full Text] [Related]
6. Determination of the interaction of 3S-hydroxy-10,11-dihydroquinidine on the pharmacokinetics and pharmacodynamics of warfarin.
Trenk D; Möhrke W; Warth L; Jähnchen E
Arzneimittelforschung; 1993 Aug; 43(8):836-41. PubMed ID: 8216438
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of effects of terbinafine on single oral dose pharmacokinetics and anticoagulant actions of warfarin in healthy volunteers.
Guerret M; Francheteau P; Hubert M
Pharmacotherapy; 1997; 17(4):767-73. PubMed ID: 9250555
[TBL] [Abstract][Full Text] [Related]
8. Absence of a pharmacokinetic interaction between etanercept and warfarin.
Zhou H; Patat A; Parks V; Buckwalter M; Metzger D; Korth-Bradley J
J Clin Pharmacol; 2004 May; 44(5):543-50. PubMed ID: 15102876
[TBL] [Abstract][Full Text] [Related]
9. Warfarin maintenance dose adjustment with indirect pharmacodynamic model in rats.
Cao YG; Liu XQ; Chen YC; Hao K; Wang GJ
Eur J Pharm Sci; 2007 Feb; 30(2):175-80. PubMed ID: 17169538
[TBL] [Abstract][Full Text] [Related]
10. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
[TBL] [Abstract][Full Text] [Related]
11. Significant pharmacokinetic and pharmacodynamic interaction of warfarin with the NO-independent sGC activator HMR1766.
Oberwittler H; Hirschfeld-Warneken A; Wesch R; Willerich H; Teichert L; Lehr KH; Ding R; Haefeli WE; Mikus G
J Clin Pharmacol; 2007 Jan; 47(1):70-7. PubMed ID: 17192504
[TBL] [Abstract][Full Text] [Related]
12. Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients.
McAleer SD; Foondun AS; Feely M; Chrystyn H
Chirality; 1997; 9(1):13-6. PubMed ID: 9094197
[TBL] [Abstract][Full Text] [Related]
13. The stereoselective interaction of warfarin and metronidazole in man.
O'Reilly RA
N Engl J Med; 1976 Aug; 295(7):354-7. PubMed ID: 934223
[TBL] [Abstract][Full Text] [Related]
14. Kiiv, an in vivo parameter for predicting the magnitude of a drug interaction arising from competitive enzyme inhibition.
Neal JM; Kunze KL; Levy RH; O'Reilly RA; Trager WF
Drug Metab Dispos; 2003 Aug; 31(8):1043-8. PubMed ID: 12867493
[TBL] [Abstract][Full Text] [Related]
15. Influence of vinpocetine on warfarin-induced inhibition of coagulation.
Hitzenberger G; Sommer W; Grandt R
Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):323-8. PubMed ID: 2272713
[TBL] [Abstract][Full Text] [Related]
16. Bisoprolol: studies of potential interactions with theophylline and warfarin in healthy volunteers.
Warrington SJ; Johnston A; Lewis Y; Murphy M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S164-8. PubMed ID: 11527121
[TBL] [Abstract][Full Text] [Related]
17. Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.
Bjornsson TD; Meffin PJ; Swezey S; Blaschke TF
J Pharmacol Exp Ther; 1979 Sep; 210(3):316-21. PubMed ID: 480183
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
Modi NB; Kell S; Simon M; Vargas R
J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
[TBL] [Abstract][Full Text] [Related]
19. Drug-drug interaction study to assess the effects of multiple-dose pitavastatin on steady-state warfarin in healthy adult volunteers.
Inagaki Y; Hunt T; Arana B; Gosho M; Morgan R
J Clin Pharmacol; 2011 Sep; 51(9):1302-9. PubMed ID: 21228405
[TBL] [Abstract][Full Text] [Related]
20. Predicting warfarin maintenance dosage based on initial response.
Miller DR; Brown MA
Am J Hosp Pharm; 1979 Oct; 36(10):1351-5. PubMed ID: 507078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
